Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like) (APC-like)

 APCL_HUMAN              Reviewed;        2303 AA.
O95996; Q05BW4; Q9UBZ1; Q9UEM8; Q9UQJ8; Q9UQJ9; Q9Y632;
15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
01-MAY-1999, sequence version 1.
25-OCT-2017, entry version 138.
RecName: Full=Adenomatous polyposis coli protein 2;
AltName: Full=Adenomatous polyposis coli protein-like;
Short=APC-like;
Name=APC2; Synonyms=APCL;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
CTNNB1, AND TISSUE SPECIFICITY.
TISSUE=Brain;
PubMed=9823329;
Nakagawa H., Murata Y., Koyama K., Fujiyama A., Miyoshi Y., Monden M.,
Akiyama T., Nakamura Y.;
"Identification of a brain-specific APC homologue, APCL, and its
interaction with beta-catenin.";
Cancer Res. 58:5176-5181(1998).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
PubMed=10551328; DOI=10.1111/j.1349-7006.1999.tb00845.x;
Nakagawa H., Koyama K., Monden M., Nakamura Y.;
"Analysis of APCL, a brain-specific adenomatous polyposis coli
homologue, for mutations and expression in brain tumors.";
Jpn. J. Cancer Res. 90:982-986(1999).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-1521 (ISOFORM 2), AND NUCLEOTIDE
SEQUENCE [GENOMIC DNA] OF 34-86 AND 476-555 (ISOFORM 2).
Carr I.M., Markham A.F., Colleta P.L., Wai L., Askham J., Morrison E.,
Meredith D.M.;
"APC2 alternatively spliced cDNA sequence.";
Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-731 (ISOFORM 3), NUCLEOTIDE SEQUENCE
[GENOMIC DNA] OF 618-2303 (ISOFORM 3), FUNCTION, INTERACTION WITH
AXIN2, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
TISSUE=Kidney;
PubMed=10021369; DOI=10.1016/S0960-9822(99)80024-4;
van Es J.H., Kirkpatrick C., van de Wetering M., Molenaar M.,
Miles A., Kuipers J., Destree O., Peifer M., Clevers H.;
"Identification of APC2, a homologue of the adenomatous polyposis coli
tumour suppressor.";
Curr. Biol. 9:105-108(1999).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-702 (ISOFORM 1).
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
INTERACTION WITH TP53BP2, AND SUBCELLULAR LOCATION.
PubMed=10646860;
Nakagawa H., Koyama K., Murata Y., Morito M., Akiyama T., Nakamura Y.;
"APCL, a central nervous system-specific homologue of adenomatous
polyposis coli tumor suppressor, binds to p53-binding protein 2 and
translocates it to the perinucleus.";
Cancer Res. 60:101-105(2000).
[8]
INTERACTION WITH MAPRE1 AND MAPRE3, AND SUBCELLULAR LOCATION.
TISSUE=Fetal brain;
PubMed=10644998; DOI=10.1038/sj.onc.1203308;
Nakagawa H., Koyama K., Murata Y., Morito M., Akiyama T., Nakamura Y.;
"EB3, a novel member of the EB1 family preferentially expressed in the
central nervous system, binds to a CNS-specific APC homologue.";
Oncogene 19:210-216(2000).
[9]
FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH APC, AND TISSUE
SPECIFICITY.
PubMed=11691822;
Jarrett C.R., Blancato J., Cao T., Bressette D.S., Cepeda M.,
Young P.E., King C.R., Byers S.W.;
"Human APC2 localization and allelic imbalance.";
Cancer Res. 61:7978-7984(2001).
[10]
INVOLVEMENT IN SOTOS3, FUNCTION, SUBCELLULAR LOCATION, AND REGION.
PubMed=25753423; DOI=10.1016/j.celrep.2015.02.011;
Almuriekhi M., Shintani T., Fahiminiya S., Fujikawa A., Kuboyama K.,
Takeuchi Y., Nawaz Z., Nadaf J., Kamel H., Kitam A.K., Samiha Z.,
Mahmoud L., Ben-Omran T., Majewski J., Noda M.;
"Loss-of-function mutation in APC2 causes Sotos syndrome features.";
Cell Rep. 0:0-0(2015).
[11]
VARIANTS [LARGE SCALE ANALYSIS] SER-562 AND SER-2003.
PubMed=16959974; DOI=10.1126/science.1133427;
Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
Vogelstein B., Kinzler K.W., Velculescu V.E.;
"The consensus coding sequences of human breast and colorectal
cancers.";
Science 314:268-274(2006).
-!- FUNCTION: Stabilizes microtubules and may regulate actin fiber
dynamics through the activation of Rho family GTPases
(PubMed:25753423). May also function in Wnt signaling by promoting
the rapid degradation of CTNNB1 (PubMed:10021369, PubMed:11691822,
PubMed:9823329). {ECO:0000269|PubMed:10021369,
ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423,
ECO:0000269|PubMed:9823329}.
-!- SUBUNIT: Interacts with PSRC1 (By similarity). Interacts with APC,
CTNNB1, MAPRE1, MAPRE3, TP53BP2 and possibly with AXIN2.
{ECO:0000250, ECO:0000269|PubMed:10021369,
ECO:0000269|PubMed:10644998, ECO:0000269|PubMed:10646860,
ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:9823329}.
-!- INTERACTION:
Q15691:MAPRE1; NbExp=3; IntAct=EBI-1053045, EBI-1004115;
Q9UPY8:MAPRE3; NbExp=7; IntAct=EBI-1053045, EBI-726739;
Q13625:TP53BP2; NbExp=4; IntAct=EBI-1053045, EBI-77642;
-!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
{ECO:0000269|PubMed:10644998, ECO:0000269|PubMed:11691822,
ECO:0000269|PubMed:25753423}. Golgi apparatus
{ECO:0000269|PubMed:11691822}. Cytoplasm
{ECO:0000269|PubMed:11691822}. Cytoplasm, perinuclear region
{ECO:0000269|PubMed:10646860}. Note=Associated with actin
filaments (PubMed:11691822, PubMed:25753423). Associated with
microtubule network (PubMed:10644998, PubMed:11691822,
PubMed:25753423). {ECO:0000269|PubMed:10644998,
ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=3;
Name=1;
IsoId=O95996-1; Sequence=Displayed;
Name=2;
IsoId=O95996-2; Sequence=VSP_030106;
Name=3;
IsoId=O95996-3; Sequence=VSP_030107;
-!- TISSUE SPECIFICITY: Widely expressed (at protein level).
Specifically expressed in the CNS. {ECO:0000269|PubMed:10021369,
ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:9823329}.
-!- DEVELOPMENTAL STAGE: Expressed in fetal brain.
{ECO:0000269|PubMed:10021369}.
-!- DISEASE: Sotos syndrome 3 (SOTOS3) [MIM:617169]: A form of Sotos
syndrome, a childhood overgrowth syndrome characterized by
prenatal and postnatal overgrowth, developmental delay, mental
retardation, advanced bone age, and abnormal craniofacial
morphology. SOTOS3 patients do not have advanced bone age,
hypotonia, seizures, or autism. SOTOS3 transmission pattern is
consistent with autosomal recessive inheritance.
{ECO:0000269|PubMed:25753423}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the adenomatous polyposis coli (APC)
family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAD28183.1; Type=Frameshift; Positions=1322, 1338; Evidence={ECO:0000305};
Sequence=AAF01784.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence.; Evidence={ECO:0000305};
Sequence=CAA10317.1; Type=Erroneous initiation; Evidence={ECO:0000305};
Sequence=CAB61207.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AB012162; BAA34611.1; -; mRNA.
EMBL; AB022529; BAA75469.1; -; Genomic_DNA.
EMBL; CH471139; EAW69498.1; -; Genomic_DNA.
EMBL; AF110334; AAD28183.1; ALT_FRAME; mRNA.
EMBL; AF110335; AAD29273.1; -; Genomic_DNA.
EMBL; AF110337; AAD29274.1; -; Genomic_DNA.
EMBL; AF110336; AAD29274.1; JOINED; Genomic_DNA.
EMBL; AF128222; AAF01784.1; ALT_SEQ; mRNA.
EMBL; AJ012652; CAB61207.1; ALT_SEQ; mRNA.
EMBL; AJ131187; CAA10317.1; ALT_INIT; Genomic_DNA.
EMBL; BC032573; AAH32573.1; -; mRNA.
CCDS; CCDS12068.1; -. [O95996-1]
RefSeq; NP_005874.1; NM_005883.2. [O95996-1]
RefSeq; XP_006722672.1; XM_006722609.3. [O95996-1]
UniGene; Hs.446376; -.
ProteinModelPortal; O95996; -.
SMR; O95996; -.
BioGrid; 115585; 6.
ELM; O95996; -.
IntAct; O95996; 4.
STRING; 9606.ENSP00000233607; -.
iPTMnet; O95996; -.
PhosphoSitePlus; O95996; -.
BioMuta; APC2; -.
PaxDb; O95996; -.
PeptideAtlas; O95996; -.
PRIDE; O95996; -.
Ensembl; ENST00000233607; ENSP00000233607; ENSG00000115266. [O95996-1]
Ensembl; ENST00000535453; ENSP00000442954; ENSG00000115266. [O95996-1]
GeneID; 10297; -.
KEGG; hsa:10297; -.
UCSC; uc002lsr.1; human. [O95996-1]
CTD; 10297; -.
DisGeNET; 10297; -.
EuPathDB; HostDB:ENSG00000115266.11; -.
GeneCards; APC2; -.
H-InvDB; HIX0039920; -.
HGNC; HGNC:24036; APC2.
HPA; HPA078002; -.
MalaCards; APC2; -.
MIM; 612034; gene.
MIM; 617169; phenotype.
neXtProt; NX_O95996; -.
OpenTargets; ENSG00000115266; -.
PharmGKB; PA134906843; -.
eggNOG; KOG2122; Eukaryota.
eggNOG; ENOG410XR2V; LUCA.
GeneTree; ENSGT00530000063749; -.
HOVERGEN; HBG104821; -.
InParanoid; O95996; -.
KO; K02085; -.
OMA; FSLQWES; -.
OrthoDB; EOG091G00D4; -.
PhylomeDB; O95996; -.
TreeFam; TF106496; -.
SignaLink; O95996; -.
SIGNOR; O95996; -.
GenomeRNAi; 10297; -.
PRO; PR:O95996; -.
Proteomes; UP000005640; Chromosome 19.
Bgee; ENSG00000115266; -.
CleanEx; HS_APC2; -.
ExpressionAtlas; O95996; baseline and differential.
Genevisible; O95996; HS.
GO; GO:0005884; C:actin filament; IDA:BHF-UCL.
GO; GO:0016342; C:catenin complex; IDA:MGI.
GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
GO; GO:0031258; C:lamellipodium membrane; IDA:BHF-UCL.
GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
GO; GO:0015630; C:microtubule cytoskeleton; IDA:BHF-UCL.
GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
GO; GO:0008013; F:beta-catenin binding; IDA:MGI.
GO; GO:0008017; F:microtubule binding; IEA:InterPro.
GO; GO:0090630; P:activation of GTPase activity; IMP:UniProtKB.
GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB.
GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL.
GO; GO:0035414; P:negative regulation of catenin import into nucleus; IDA:BHF-UCL.
GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
Gene3D; 1.25.10.10; -; 3.
InterPro; IPR026837; APC2.
InterPro; IPR009234; APC_basic_dom.
InterPro; IPR026831; APC_dom.
InterPro; IPR026818; Apc_fam.
InterPro; IPR032038; APC_N.
InterPro; IPR036149; APC_N_sf.
InterPro; IPR009223; APC_rpt.
InterPro; IPR011989; ARM-like.
InterPro; IPR016024; ARM-type_fold.
InterPro; IPR000225; Armadillo.
InterPro; IPR009224; SAMP.
PANTHER; PTHR12607; PTHR12607; 1.
PANTHER; PTHR12607:SF3; PTHR12607:SF3; 1.
Pfam; PF05956; APC_basic; 1.
Pfam; PF16689; APC_N_CC; 1.
Pfam; PF05923; APC_r; 4.
Pfam; PF00514; Arm; 1.
Pfam; PF05924; SAMP; 2.
SMART; SM00185; ARM; 6.
SUPFAM; SSF48371; SSF48371; 1.
SUPFAM; SSF58050; SSF58050; 1.
SUPFAM; SSF82931; SSF82931; 1.
1: Evidence at protein level;
Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
Cytoskeleton; Golgi apparatus; Microtubule; Phosphoprotein;
Polymorphism; Reference proteome; Repeat; Wnt signaling pathway.
CHAIN 1 2303 Adenomatous polyposis coli protein 2.
/FTId=PRO_0000313686.
REPEAT 302 341 ARM 1.
REPEAT 479 518 ARM 2.
REPEAT 522 562 ARM 3.
REPEAT 566 609 ARM 4.
REPEAT 615 654 ARM 5.
REPEAT 657 696 ARM 6.
REPEAT 1058 1077 1.
REPEAT 1150 1169 2.
REPEAT 1263 1282 3.
REPEAT 1391 1410 4.
REPEAT 1568 1587 5.
REGION 1058 1587 5 X 20 AA approximate repeat of F-X-V-E-
X-T-P-X-C-F-S-R-X-S-S-L-S-S-L-S.
REGION 1058 1587 Interaction with CTNNB1.
{ECO:0000269|PubMed:9823329}.
REGION 1821 1900 Required for localization to microtubules
and function in microtubule
stabilization.
{ECO:0000269|PubMed:25753423}.
REGION 2067 2144 Interaction with MAPRE1 and MAPRE3.
{ECO:0000269|PubMed:10644998}.
COILED 8 59 {ECO:0000255}.
COILED 840 864 {ECO:0000255}.
COMPBIAS 1145 1196 Ser-rich.
COMPBIAS 1518 1622 Pro-rich.
COMPBIAS 1765 1953 Pro-rich.
MOD_RES 1585 1585 Phosphoserine.
{ECO:0000250|UniProtKB:Q9Z1K7}.
MOD_RES 1587 1587 Phosphoserine.
{ECO:0000250|UniProtKB:Q9Z1K7}.
VAR_SEQ 168 441 Missing (in isoform 2).
{ECO:0000303|Ref.4}.
/FTId=VSP_030106.
VAR_SEQ 175 175 Missing (in isoform 3).
{ECO:0000303|PubMed:10021369}.
/FTId=VSP_030107.
VARIANT 562 562 A -> S (in a breast cancer sample;
somatic mutation).
{ECO:0000269|PubMed:16959974}.
/FTId=VAR_037703.
VARIANT 2003 2003 G -> S (in a breast cancer sample;
somatic mutation).
{ECO:0000269|PubMed:16959974}.
/FTId=VAR_037704.
VARIANT 2241 2241 S -> A (in dbSNP:rs265277).
/FTId=VAR_037705.
CONFLICT 463 463 Missing (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 526 527 KV -> NL (in Ref. 4; AAD28183/AAD29274).
{ECO:0000305}.
CONFLICT 566 566 E -> A (in Ref. 5; AAF01784/CAB61207).
{ECO:0000305}.
CONFLICT 816 816 L -> Q (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 971 971 L -> P (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 1106 1106 S -> I (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 1140 1140 E -> G (in Ref. 5; CAA10317).
{ECO:0000305}.
CONFLICT 1188 1188 Q -> H (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 1361 1361 A -> G (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 1456 1456 R -> P (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 1515 1515 D -> V (in Ref. 4; AAD28183).
{ECO:0000305}.
CONFLICT 2219 2219 A -> V (in Ref. 5; CAA10317).
{ECO:0000305}.
SEQUENCE 2303 AA; 243949 MW; 7BF940183ACD643D CRC64;
MASSVAPYEQ LVRQVEALKA ENSHLRQELR DNSSHLSKLE TETSGMKEVL KHLQGKLEQE
ARVLVSSGQT EVLEQLKALQ MDITSLYNLK FQPPTLGPEP AARTPEGSPV HGSGPSKDSF
GELSRATIRL LEELDRERCF LLNEIEKEEK EKLWYYSQLQ GLSKRLDELP HVETQFSMQM
DLIRQQLEFE AQHIRSLMEE RFGTSDEMVQ RAQIRASRLE QIDKELLEAQ DRVQQTEPQA
LLAVKSVPVD EDPETEVPTH PEDGTPQPGN SKVEVVFWLL SMLATRDQED TARTLLAMSS
SPESCVAMRR SGCLPLLLQI LHGTEAAAGG RAGAPGAPGA KDARMRANAA LHNIVFSQPD
QGLARKEMRV LHVLEQIRAY CETCWDWLQA RDGGPEGGGA GSAPIPIEPQ ICQATCAVMK
LSFDEEYRRA MNELGGLQAV AELLQVDYEM HKMTRDPLNL ALRRYAGMTL TNLTFGDVAN
KATLCARRGC MEAIVAQLAS DSEELHQVVS SILRNLSWRA DINSKKVLRE AGSVTALVQC
VLRATKESTL KSVLSALWNL SAHSTENKAA ICQVDGALGF LVSTLTYKCQ SNSLAIIESG
GGILRNVSSL VATREDYRQV LRDHNCLQTL LQHLTSHSLT IVSNACGTLW NLSARSARDQ
ELLWDLGAVG MLRNLVHSKH KMIAMGSAAA LRNLLAHRPA KHQAAATAVS PGSCVPSLYV
RKQRALEAEL DARHLAQALE HLEKQGPPAA EAATKKPLPP LRHLDGLAQD YASDSGCFDD
DDAPSSLAAA AATGEPASPA ALSLFLGSPF LQGQALARTP PTRRGGKEAE KDTSGEAAVA
AKAKAKLALA VARIDQLVED ISALHTSSDD SFSLSSGDPG QEAPREGRAQ SCSPCRGPEG
GRREAGSRAH PLLRLKAAHA SLSNDSLNSG SASDGYCPRE HMLPCPLAAL ASRREDPRCG
QPRPSRLDLD LPGCQAEPPA REATSADARV RTIKLSPTYQ HVPLLEGASR AGAEPLAGPG
ISPGARKQAW LPADHLSKVP EKLAAAPLSV ASKALQKLAA QEGPLSLSRC SSLSSLSSAG
RPGPSEGGDL DDSDSSLEGL EEAGPSEAEL DSTWRAPGAT SLPVAIPAPR RNRGRGLGVE
DATPSSSSEN YVQETPLVLS RCSSVSSLGS FESPSIASSI PSEPCSGQGS GTISPSELPD
SPGQTMPPSR SKTPPLAPAP QGPPEATQFS LQWESYVKRF LDIADCRERC RLPSELDAGS
VRFTVEKPDE NFSCASSLSA LALHEHYVQQ DVELRLLPSA CPERGGGAGG AGLHFAGHRR
REEGPAPTGS RPRGAADQEL ELLRECLGAA VPARLRKVAS ALVPGRRALP VPVYMLVPAP
APAQEDDSCT DSAEGTPVNF SSAASLSDET LQGPPRDQPG GPAGRQRPTG RPTSARQAMG
HRHKAGGAGR SAEQSRGAGK NRAGLELPLG RPPSAPADKD GSKPGRTRGD GALQSLCLTT
PTEEAVYCFY GNDSDEEPPA AAPTPTHRRT SAIPRAFTRE RPQGRKEAPA PSKAAPAAPP
PARTQPSLIA DETPPCYSLS SSASSLSEPE PSEPPAVHPR GREPAVTKDP GPGGGRDSSP
SPRAAEELLQ RCISSALPRR RPPVSGLRRR KPRATRLDER PAEGSRERGE EAAGSDRASD
LDSVEWRAIQ EGANSIVTWL HQAAAATREA SSESDSILSF VSGLSVGSTL QPPKHRKGRQ
AEGEMGSARR PEKRGAASVK TSGSPRSPAG PEKPRGTQKT TPGVPAVLRG RTVIYVPSPA
PRAQPKGTPG PRATPRKVAP PCLAQPAAPA KVPSPGQQRS RSLHRPAKTS ELATLSQPPR
SATPPARLAK TPSSSSSQTS PASQPLPRKR PPVTQAAGAL PGPGASPVPK TPARTLLAKQ
HKTQRSPVRI PFMQRPARRG PPPLARAVPE PGPRGRAGTE AGPGARGGRL GLVRVASALS
SGSESSDRSG FRRQLTFIKE SPGLRRRRSE LSSAESAASA PQGASPRRGR PALPAVFLCS
SRCEELRAAP RQGPAPARQR PPAARPSPGE RPARRTTSES PSRLPVRAPA ARPETVKRYA
SLPHISVARR PDGAVPAAPA SADAARRSSD GEPRPLPRVA APGTTWRRIR DEDVPHILRS
TLPATALPLR GSTPEDAPAG PPPRKTSDAV VQTEEVAAPK TNSSTSPSLE TREPPGAPAG
GQLSLLGSDV DGPSLAKAPI SAPFVHEGLG VAVGGFPASR HGSPSRSARV PPFNYVPSPM
VVAATTDSAA EKAPATASAT LLE


Related products :

Catalog number Product name Quantity
Y059020 Anti_mouse adenomatous polyposis coli protein (APC) 100ug
EH1239 Adenomatous polyposis coli protein Elisa Kit 96T
G197 Anti_mouse adenomatous polyposis coli protein (APC) 100ug
CSB-EL001894HU Human Adenomatous polyposis coli protein(APC) ELISA kit 96T
CSB-EL001894MO Mouse Adenomatous polyposis coli protein(APC) ELISA kit 96T
E1490h Mouse ELISA Kit FOR Adenomatous polyposis coli protein 2 96T
CSB-EL001895HU Human Adenomatous polyposis coli protein 2(APC2) ELISA kit 96T
CSB-EL001894MO Mouse Adenomatous polyposis coli protein(APC) ELISA kit SpeciesMouse 96T
Y059020 Anti-mouse adenomatous polyposis coli protein APC antibody 250ug
CSB-EL001894HU Human Adenomatous polyposis coli protein(APC) ELISA kit SpeciesHuman 96T
G197 Anti-mouse adenomatous polyposis coli protein (APC) Antibody 100ug
Y059020 Anti-mouse adenomatous polyposis coli protein (APC) Antibody 100ug
G197 Anti-mouse adenomatous polyposis coli protein APC antibody 250ug
CSB-EL001895HU Human Adenomatous polyposis coli protein 2(APC2) ELISA kit SpeciesHuman 96T
MEDCLA821 Adenomatous Polyposis Coli Protein (APCP), Clone EMM43, Mab anti_; paraffin, IH 1 ml.
GWB-1B5EEC Adenomatous Polyposis Coli Protein (APC) Rabbit anti-Human Polyclonal (C-Terminus) Antibody
GWB-45D888 Adenomatous Polyposis Coli Protein (APC) Rabbit anti-Human Polyclonal (C-Terminus) Antibody
CSB-EL001894RA Rat adenomatous polyposis coli (APC) ELISA kit 96T
201-20-0366 APC{adenomatous polyposis coli}rabbit.pAb 0.1ml
APCDD1 APC Gene adenomatous polyposis coli
AE56121RA Rat Adenomatous polyposis coli (APC) ELISA Kit 48T
CSB-EL001894RA Rat adenomatous polyposis coli (APC) ELISA kit SpeciesRat 96T
17-4084 Polyclonal antibody Anti-Adenomatous Polyposis Coli (APC) 200 μl
bs-3680R Rabbit Anti-Adenomatous Polyposis Coli Polyclonal Antibody 100ul
bs-3680R-Cy5.5 Rabbit Anti-Adenomatous Polyposis Coli Polyclonal Antibody, Cy5.5 Conjugated 100ul


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur